Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

John H Stone, M.D.

Co-Author

This page shows the publications co-authored by John Stone and Zachary Wallace.
Connection Strength

18.044
  1. Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide? Front Immunol. 2019; 10:2855.
    View in: PubMed
    Score: 0.848
  2. Reply. Arthritis Rheumatol. 2020 01; 72(1):201-202.
    View in: PubMed
    Score: 0.845
  3. Disease Activity, Antineutrophil Cytoplasmic Antibody Type, and Lipid Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2019 11; 71(11):1879-1887.
    View in: PubMed
    Score: 0.835
  4. Immunoglobulin G4-related Disease. Clin Chest Med. 2019 09; 40(3):583-597.
    View in: PubMed
    Score: 0.832
  5. Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis. Ann Rheum Dis. 2020 04; 79(4):e40.
    View in: PubMed
    Score: 0.799
  6. An International Multispecialty Validation Study of the IgG4-Related Disease Responder Index. Arthritis Care Res (Hoboken). 2018 11; 70(11):1671-1678.
    View in: PubMed
    Score: 0.786
  7. Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res (Hoboken). 2017 07; 69(7):1004-1010.
    View in: PubMed
    Score: 0.716
  8. Association of IgG4-Related Disease With History of Malignancy. Arthritis Rheumatol. 2016 09; 68(9):2283-9.
    View in: PubMed
    Score: 0.676
  9. Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology (Oxford). 2016 Jun; 55(6):1000-8.
    View in: PubMed
    Score: 0.651
  10. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol. 2015 Sep; 67(9):2466-75.
    View in: PubMed
    Score: 0.631
  11. An update on IgG4-related disease. Curr Opin Rheumatol. 2015 Jan; 27(1):83-90.
    View in: PubMed
    Score: 0.602
  12. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015 Jan; 74(1):190-5.
    View in: PubMed
    Score: 0.576
  13. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum. 2014 Jun; 43(6):806-17.
    View in: PubMed
    Score: 0.557
  14. IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore). 2013 Jul; 92(4):206-216.
    View in: PubMed
    Score: 0.543
  15. Dr. Wallace and Dr. Stone reply. J Rheumatol. 2013 Jul; 40(7):1232.
    View in: PubMed
    Score: 0.543
  16. Refractory relapsing polychondritis treated with serial success with interleukin 6 receptor blockade. J Rheumatol. 2013 Jan; 40(1):100-1.
    View in: PubMed
    Score: 0.524
  17. IgG4-related systemic disease as a cause of "idiopathic" orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol. 2012 Jan-Feb; 57(1):26-33.
    View in: PubMed
    Score: 0.483
  18. The Association of Illness-Related Uncertainty with Mental Health in Systemic Autoimmune Rheumatic Diseases. J Rheumatol. 2022 Apr 01.
    View in: PubMed
    Score: 0.249
  19. Derivation and Validation of Algorithms to Identify Patients With Immunoglobulin-G4-Related Disease Using Administrative Claims Data. ACR Open Rheumatol. 2022 Apr; 4(4):371-377.
    View in: PubMed
    Score: 0.246
  20. The Effects of Treatment on Body Mass Index in Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA Trial. Rheumatol Ther. 2022 Apr; 9(2):497-508.
    View in: PubMed
    Score: 0.244
  21. The association of smoking with immunoglobulin G4-related disease: a case-control study. Rheumatology (Oxford). 2021 11 03; 60(11):5310-5317.
    View in: PubMed
    Score: 0.242
  22. Validation of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis as the Cause of End-Stage Renal Disease in the US Renal Data System. ACR Open Rheumatol. 2022 Jan; 4(1):8-12.
    View in: PubMed
    Score: 0.241
  23. Association of renal transplantation with reduced risk of myocardial infarction and ischemic stroke in ANCA-associated vasculitis: An observational cohort study. Semin Arthritis Rheum. 2021 12; 51(6):1180-1185.
    View in: PubMed
    Score: 0.240
  24. Perceived Risk and Associated Shielding Behaviors in Patients With Rheumatoid Arthritis During the Coronavirus 2019 Pandemic. ACR Open Rheumatol. 2021 Dec; 3(12):834-841.
    View in: PubMed
    Score: 0.239
  25. ANCA-associated Vasculitis Management in the United States: Data From the Rheumatology Informatics System for Effectiveness (RISE) Registry. J Rheumatol. 2021 07; 48(7):1060-1064.
    View in: PubMed
    Score: 0.230
  26. Topic modeling to characterize the natural history of ANCA-Associated vasculitis from clinical notes: A proof of concept study. Semin Arthritis Rheum. 2021 02; 51(1):150-157.
    View in: PubMed
    Score: 0.228
  27. Lifetime Allergy Symptoms in IgG4-Related Disease: A Case-Control Study. Arthritis Care Res (Hoboken). 2020 Dec 20.
    View in: PubMed
    Score: 0.228
  28. Treatment Delays Associated With Prior Authorization for Infusible Medications: A Cohort Study. Arthritis Care Res (Hoboken). 2020 11; 72(11):1543-1549.
    View in: PubMed
    Score: 0.226
  29. All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type. Rheumatology (Oxford). 2020 09 01; 59(9):2308-2315.
    View in: PubMed
    Score: 0.223
  30. Association of Cigarette Smoking With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. JAMA Intern Med. 2020 06 01; 180(6):870-876.
    View in: PubMed
    Score: 0.219
  31. Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing Analysis. ACR Open Rheumatol. 2020 May; 2(5):261-268.
    View in: PubMed
    Score: 0.217
  32. Immunoglobulin G and immunoglobulin G subclass concentrations differ according to sex and race. Ann Allergy Asthma Immunol. 2020 08; 125(2):190-195.e2.
    View in: PubMed
    Score: 0.216
  33. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020 01; 79(1):77-87.
    View in: PubMed
    Score: 0.212
  34. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis Rheumatol. 2020 01; 72(1):7-19.
    View in: PubMed
    Score: 0.212
  35. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis. 2019 03; 78(3):406-412.
    View in: PubMed
    Score: 0.199
  36. Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis. Medicine (Baltimore). 2018 Oct; 97(42):e12631.
    View in: PubMed
    Score: 0.195
  37. Improving Mortality in End-Stage Renal Disease Due to Granulomatosis With Polyangiitis (Wegener's) From 1995 to 2014: Data From the United States Renal Data System. Arthritis Care Res (Hoboken). 2018 10; 70(10):1495-1500.
    View in: PubMed
    Score: 0.194
  38. Improved survival with renal transplantation for end-stage renal disease due to granulomatosis with polyangiitis: data from the United States Renal Data System. Ann Rheum Dis. 2018 09; 77(9):1333-1338.
    View in: PubMed
    Score: 0.190
  39. Reducing glucocorticoid duration in ANCA-associated vasculitis: A pilot trial. Semin Arthritis Rheum. 2018 10; 48(2):288-292.
    View in: PubMed
    Score: 0.187
  40. Emerging Treatment Models in Rheumatology: IgG4-Related Disease: Insights Into Human Immunology and Targeted Therapies. Arthritis Rheumatol. 2017 09; 69(9):1722-1732.
    View in: PubMed
    Score: 0.180
  41. Nationwide Trends in Hospitalizations and In-Hospital Mortality in Granulomatosis With Polyangiitis (Wegener's). Arthritis Care Res (Hoboken). 2017 06; 69(6):915-921.
    View in: PubMed
    Score: 0.177
  42. Large vessel involvement by IgG4-related disease. Medicine (Baltimore). 2016 Jul; 95(28):e3344.
    View in: PubMed
    Score: 0.167
  43. Improved survival in granulomatosis with polyangiitis: A general population-based study. Semin Arthritis Rheum. 2016 Feb; 45(4):483-9.
    View in: PubMed
    Score: 0.157
  44. Response to: 'Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al. Ann Rheum Dis. 2015 Aug; 74(8):e47.
    View in: PubMed
    Score: 0.154
  45. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015 Jun; 74(6):1171-7.
    View in: PubMed
    Score: 0.152
  46. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis. 2015 Dec; 74(12):2236-43.
    View in: PubMed
    Score: 0.147
  47. Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis. Pancreatology. 2021 Oct; 21(7):1395-1401.
    View in: PubMed
    Score: 0.059
  48. Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis. Genome Med. 2021 02 28; 13(1):35.
    View in: PubMed
    Score: 0.058
  49. Prostate and pancreas involvement are linked in IgG4-related disease. Semin Arthritis Rheum. 2020 12; 50(6):1245-1251.
    View in: PubMed
    Score: 0.056
  50. CD4+ and CD8+ cytotoxic T lymphocytes may induce mesenchymal cell apoptosis in IgG4-related disease. J Allergy Clin Immunol. 2021 01; 147(1):368-382.
    View in: PubMed
    Score: 0.055
  51. Disease Severity Linked to Increase in Autoantibody Diversity in IgG4-Related Disease. Arthritis Rheumatol. 2020 04; 72(4):687-693.
    View in: PubMed
    Score: 0.054
  52. Phospholipase A2 receptor-associated membranous nephropathy in a patient with IgG4-related disease: A case report. Medicine (Baltimore). 2019 May; 98(20):e15616.
    View in: PubMed
    Score: 0.051
  53. Identification of galectin-3 as an autoantigen in patients with IgG4-related disease. J Allergy Clin Immunol. 2019 02; 143(2):736-745.e6.
    View in: PubMed
    Score: 0.048
  54. Lymphomas in IgG4-related disease: clinicopathologic features in a Western population. Virchows Arch. 2018 May; 472(5):839-852.
    View in: PubMed
    Score: 0.046
  55. Atypical IgG4+ Plasmacytic Proliferations and Lymphomas: Characterization of 11 Cases. Am J Clin Pathol. 2017 Sep 01; 148(3):215-235.
    View in: PubMed
    Score: 0.045
  56. Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease. J Allergy Clin Immunol. 2016 09; 138(3):825-838.
    View in: PubMed
    Score: 0.041
  57. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheumatol. 2015 Jul; 67(7):1688-99.
    View in: PubMed
    Score: 0.039
  58. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014 Sep; 134(3):679-87.
    View in: PubMed
    Score: 0.036
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.